 15. Hepatic disease as indicated by AST or ALT 3 × ULN. Patients with AST andor ALT 3 × ULN and 5 × ULN are eligible if acute, not accompanied by a total bilirubin 2xULN and documented by the investigator as being directly related to cIAI. 